Clinical Trial Update: Romiplostim N01 for Platelet Recovery After Haploidentical HSCT [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Romiplostim N01 for platelet recovery after haploidentical hematopoietic stem cell transplantation. The study targets patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Romiplostim N01 (romiplostim)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome) | Phase 1 | Status: RECRUITING